To determine the clinical relevance of regulation of SKP2 by USP10, we performed western blot analysis of USP10 and SKP2 on primary monocytes from 11 patients with CML. This evidence concerns the gene SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive.